Chronic Migraine
Conditions
Brief summary
The aim of this study is to determine if adding manual therapy to care as usual reduces the discomfort from chronic migraine compared to care as usual alone
Interventions
DRUGCare as usual
Application of usual pharmacological care for chronic migraine
OTHERManual Therapy
5 sessions of manual therapy over 12 weeks
Sponsors
Bournemouth University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Intervention model description
pragmatic randomised control trial
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Female adults 18 years of age or older with a good command of English (to enable informed consent) Existing patients with chronic migraine as diagnosed by a clinical interview with a neurologist in line with the International Classification of Headache Diagnosis criteria (ICHD) Undergoing care as usual from the neurologist
Exclusion criteria
Currently having or had manual therapy for neck, shoulder in the last six weeks. Having a condition contraindicated for manual therapy including but not limited to inflammatory disorders, severe osteoporosis and tumours. Identification of any medical 'red flags' by the neurologist including * Evidence of any central nervous system involvement for example: * Facial palsy (presence of ptosis/Horner's syndrome) * Visual disturbance (presence of blurred vision, diplopia, hemianopia) * Speech disturbance (presence of dysarthria, dysphonia, dysphasia such as expressive or receptive) * Balance disturbance (presence of dizziness, imbalance, unsteadiness, falls) * Paraesthesia (presence, location such as upper limb/lower limb, face) * Weakness (presence, location such as upper limb/lower limb) * Known major psychiatric or psychological conditions not under control
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in migraine-related disability | 12 weeks | Headache Impact Test (HIT6). The six-item Headache Impact Test (HIT-6) provides a global measure of adverse headache impact and is used in screening and monitoring patients. The HIT-6 items measure the adverse impact of headache on social functioning, role functioning, vitality, cognitive functioning, psychological distress and the severity of headache pain. The final HIT-6 score is obtained from simple summation of the six items and ranges between 36 and 78, with larger scores reflecting greater impact. The categories used for interpretation of impact are: little or no impact (49 or less), some impact (50-55), substantial impact (56-59), and severe impact (60-78). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Migraine Specific Quality of Life Questionnaire Score (MSQoL 2.1) | 12 weeks | The 14-item instrument measures how migraines affect daily functioning across three domains: Role function Restrictions (7 items assessing how migraines limit one's daily social and work-related activities); Role function prevention (4 items assessing how migraines prevent these activities); Emotional Functional (3 items assessing the emotions associated with migraines). It uses a 6-point scale: none of the time, a little bit of the time, some of the time, a good bit of the time, most of the time, and all of the time, which are assigned scores of 1 to 6, respectively. Scores are computed as a sum of item responses and rescaled from a 0 to 100 scale such that higher scores indicate better quality of life. |
| Headache Frequency | 12 weeks | Percentage of participants with reduction in headache frequency of greater than 50% |
Countries
United Kingdom
Outcome results
None listed